Observational studyMedicine2017

Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.

Amedeo Ferdinando Capetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.